Company: LCTX
Filing Date: 2025-03-10
Form Type: 10-K
Source: 0000950170-25-036309
Chunk: 2

Company: Lineage Cell Therapeutics, Inc.
Filing Date: 2025-03-10
Form: 10-K
Item: Item 15
Chunk 2
---
30

    3.03
     
    Amended and Restated Bylaws
     
    3.1(a)
     
    8-K
     
    June 13, 2024
     
    001-12830

    INSTRUMENTS DEFINING RIGHTS OF SECURITY HOLDERS

    4.01
     
    Specimen of Common Share Certificate

    S-1
     
    December 18, 1991
     
    033-44549

    4.02*
     
    Description of Capital Stock of the Registrant

    4.03(a)
     
    Form of Common Stock Purchase Warrant issued pursuant to the Securities Purchase Agreement dated November 19, 2024, between Lineage Cell Therapeutics, Inc. and the purchaser parties thereto
     
    4.1
     
    8-K
     
    November 20, 2024
     
    001-12830

    4.03(b)
     
    Form of Placement Agent Warrant
     
    4.3
     
    8-K
     
    November 20, 2024
     
    001-12830

    4.03(c)*
     
    Warrant issued to Broadwood Partners, L.P. on January 27, 2025

    MANAGEMENT CONTRACTS AND COMPENSATORY PLANS

    10.01+
     
    Form of Indemnification Agreement entered into between the Registrant and its Directors and Officers
     
    10.1
     
    10-Q
     
    August 11, 2022
     
    001-12830

136

    10.02+
     
    Amended and Restated Employment Agreement dated September 26, 2022 between Registrant and Brian Michael Culley
     
    10.2
     
    10-Q
     
    November 10, 2022
     
    001-12830

    10.02(a)+
     
    Amendment No. 1 to Employment Agreement entered into as of March 6, 2024 between Registrant and Brian M. Culley
     
    10.1
     
    10-Q
     
    May 9, 2024
     
    001-12830

    10.03+
     
    Amended and Restated Employment Agreement dated September 26, 2022 between Registr